1
项与 Cryopreserved human umbilical cord(TissueTech, Inc.) 相关的临床试验A Phase 2, 52-Week Trial of TTAX03 vs. Saline as a Single Intra-articular Injection in Kellgren-Lawrence Grade 3-4 Knee OA
It is hypothesized that a single Intra-articular Injection of TTAX03, 100mg in 2mL of saline, will have more benefit with respect to the proportion of responders 12 weeks post-injection than an equal volume of saline, based on the OMERACT-OARSI responder criteria.
100 项与 Cryopreserved human umbilical cord(TissueTech, Inc.) 相关的临床结果
100 项与 Cryopreserved human umbilical cord(TissueTech, Inc.) 相关的转化医学
100 项与 Cryopreserved human umbilical cord(TissueTech, Inc.) 相关的专利(医药)
100 项与 Cryopreserved human umbilical cord(TissueTech, Inc.) 相关的药物交易